Tenderwize
Back to tender search

Open-House-Biologika-Rabattverträge 2026-07 - Tocilizumab

Techniker Krankenkasse·Hamburg, Germany·Deadline Apr 30, 2028 · 622 days left·Open·Supplies
Sign up to saveOpen documents
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-07 - Tocilizumab

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

The notice explicitly states this is not a public procurement under EU law; legal remedies lie with social courts, not...

No estimated value; potential volume unclear.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Conclusion of discount agreements for the active substance Tocilizumab (pharmaceutical products)
Show full summary

Open-house procedure for pharmaceutical discount agreements for Tocilizumab under §130a Abs. 8 SGB V. Techniker Krankenkasse and other German health insurers invite any qualified pharmaceutical entrepreneur to conclude a standard discount agreement. No competitive selection; all eligible participants can join anytime during the contract period (May 2026 - April 2028). Submission by email with qualified electronic signature or by post.

Risks

The notice explicitly states this is not a public procurement under EU law; legal remedies lie with social courts, not...

No estimated value; potential volume unclear.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as per §4 Abs. 18 AMG
  • Must have valid marketing authorization for the medicinal product
  • Must have seat in Germany, EU, or EEA

Requirements may be incomplete.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House-Biologika-Rabattverträge 2026-07 - Tocilizumab

Conclusion of discount agreements for the active substance Tocilizumab under an open-house procedure. Uniform conditions, no exclusivity, maximum contract period 24 months.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Apr 2026 - Apr 2028

Category

Pharmaceutical products

Deadline

Deadline Apr 30, 2028

Procurement Details

Publication date
18 Mar 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
190657-2026

Documents (1)

Procurement document 1

Similar tenders

France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord

Sep 14
6 SME lots

Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)

Aug 27
3 framework lots3 SME lots

Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș

Sep 23
1 framework lot

France – Insurance services – MARCHE DE SERVICES EN ASSURANCE

Sep 30

Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.

Sep 28

Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).

Sep 24